CLINICAL TRIAL EXPERIENCE WITH THE 9-VALENT HPV VACCINE BY RACE/ETHNICITY: A COMBINED ANALYSIS FROM SEVEN PHASE III CLINICAL STUDIES

被引：0

作者：

Clark, Liana R. ^{[1
]}

Luxembourg, Alain T. ^{[1
]}

机构：

[1] Merck & Co Inc, Rahway, NJ USA

来源：

JOURNAL OF ADOLESCENT HEALTH | 2016年 / 58卷 / 02期

关键词：

D O I：

10.1016/j.jadohealth.2015.10.246

中图分类号：

B844 [发展心理学（人类心理学）];

学科分类号：

040202 ;

摘要：

225

引用

页码：S118 / S118

页数：1

共 50 条

[21] Conducting a phase III clinical trial in children during the COVID-19 pandemic: Experience and lessons learnt from a clinical research facility of Nepal
Chapagain, Ram Hari
Maharjan, Jessica
Adhikari, Santosh
Thapa, Prabhat
Kunwar, Kshitij
Giri, Bishnu Rath
Shrestha, Nisha Jyoti
Shrestha, Anil Kumar
Shrestha, Sanjeet Kumar
Tamang, Suresh Man
Cho, Haeun
Park, Eun Lyeong
Lee, Jiyoung
Lee, Jinae
Kim, Deok Ryun
Yang, Jae Seung
Saluja, Tarun
Wartel, Anh
Lynch, Julia
Song, Katerina Rok
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (02)
[22] Cardiovascular safety of liraglutide: a pooled analysis from phase II and III liraglutide clinical development studies
Huang, Y. Y.
Marso, S. P.
Moses, A. C.
Zychma, M. J.
Buse, J. B.
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2012, 28 : 91 - 91
[23] Cardiovascular Safety of Liraglutide: A Pooled Analysis from Phase II and III Liraglutide Clinical Development Studies
Marso, Steven P.
Moses, Alan C.
Zychma, Marcin J.
Buse, John B.
CIRCULATION, 2010, 122 (21)
[24] Efficacy and Safety Analysis of Nelipepimut-S Vaccine to Prevent Breast Cancer Recurrence: A Randomized, Multicenter, Phase III Clinical Trial
Mittendorf, Elizabeth A.
Lu, Biao
Melisko, Michelle
Hiller, Julie Price
Bondarenko, Igor
Brunt, Adrian Murray
Sergii, Grybach
Petrakova, Katarina
Peoples, George E.
CLINICAL CANCER RESEARCH, 2019, 25 (14) : 4248 - 4254
[25] Severity, therapeutic, and activity tear biomarkers in dry eye disease: An analysis from a phase III clinical trial
Pinto-Fraga, Jose
Enriquez-de-Salamanca, Amalia
Calonge, Margarita
Gonzalez-Garcia, Maria J.
Lopez-Miguel, Alberto
Lopez-de la Rosa, Alberto
Garcia-Vazquez, Carmen
Calder, Virginia
Stern, Michael E.
Fernandez, Itziar
OCULAR SURFACE, 2018, 16 (03): : 368 - 376
[26] Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in 2 to 70 year old healthy people in China: A phase III double blind, randomized clinical trial
Li, Guifan
Liang, Qi
Shi, Jichun
Hu, Yuemei
Li, Hong
Wei, Wenjin
Zhu, Fengcai
Ye, Qiang
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (03) : 699 - 703
[27] The ustekinumab safety experience in patients with moderate to severe psoriasis: Results from pooled analyses of phase II and phase III clinical trial data
Gordon, Kenneth
Leonardi, Craig
Reich, Kristian
Yeilding, Newman
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB132 - AB132
[28] Safety and immunogenicity of Innovax bivalent human papillomavirus vaccine in girls 9-14 years of age: Interim analysis from a phase 3 clinical trial
Zaman, Khalequ
Schuind, Anne E.
Adjei, Samuel
Antony, Kalpana
Aponte, John J.
Buabeng, Patrick B. Y.
Qadri, Firdausi
Kemp, Troy J.
Hossain, Lokman
Pinto, Ligia A.
Sukraw, Kristen
Bhat, Niranjan
Agbenyega, Tsiri
VACCINE, 2024, 42 (09) : 2290 - 2298
[29] Results from the safety interim analysis of the adjuvant chemoradiotherapy in stomach tumors 2 trial: a multicenter, randomized phase III clinical trial
Park, Se Hoon
Lee, Jeeyun
Sohn, Tae Sung
Lim, Do Hoon
Kim, Kyoung-Mee
An, Ji Yeong
Choi, Min Gew
Lee, Jun Ho
Bae, Jae Moon
Kim, Sung
Lee, Su Jin
Kim, Seung Tae
Park, Joon Oh
Park, Young Suk
Lim, Ho Yeong
Kang, Won Ki
PRECISION AND FUTURE MEDICINE, 2019, 3 (01): : 24 - 29
[30] Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered in a prime-boost regimen among Chinese infants: a randomized, double blind phase III clinical trial
Wang, Wenjuan
Liang, Qi
Zhu, Jiahong
Zhang, Junxia
Chen, Junsheng
Xie, Sulan
Hu, Yuemei
Li, Guifan
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01)

← 1 2 3 4 5 →